Phase 2b study of PA101 for the treatment of refractory chronic cough with idiopathic pulmonary fibrosis.

Trial Profile

Phase 2b study of PA101 for the treatment of refractory chronic cough with idiopathic pulmonary fibrosis.

Planning
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs Sodium cromoglicate (Primary)
  • Indications Cough; Idiopathic pulmonary fibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2016 New trial record
    • 07 Sep 2016 Based on the results from other Phase II trial (see profile 254592) company is planning to start this trial in early 2017, as reported by Patara Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top